The Taiwan Excellence Pavilion officially opened on 9 Sept at Medical Fair Asia 2026, held at the Sands Expo & Conve...
Taiwan-based Horien Biochemical Technology has announced a major double milestone in its global expansion strategy, i.e....
PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced that th...
Taiwan-based Formosa Pharmaceuticals has submitted a Clinical Trial Application to European regulators for a pivotal stu...
GC Biopharma, a leading global pharmaceutical company based in South Korea, has announced that its Hunter syndrome treat...
Taiwan-based Lotus Pharmaceutical Co. has announced a strategic licensing and commercialisation agreement with Alvotech,...
US-based Charles River Laboratories International, and Medigen Vaccine Biologics Corp. (MVC), headquartered in Taiwan, h...
Aztron Medtech Corporation, a US-based orthopaedic device company, has announced that its Taiwan subsidiary, Astron Medt...
Japan-based Ono Pharmaceutical has announced that Ono Pharma Taiwan, a Taiwanese subsidiary of Ono, has received the add...
HanchorBio, Inc., a global clinical-stage biotechnology company developing next-generation immunotherapies for oncology ...
Energenesis Biomedical has entered into a joint development agreement with Taiwan Tanabe Seiyaku, the wholly owned ...
A growing burden demands a new approach Cardiac ablation treats AFib by targeting heart cells that send erratic signals...
Exosomes are rapidly emerging as one of the most promising frontiers in regenerative medicine, offering the therapeutic ...
As BIO Asia–Taiwan 2026 brought the region’s biotechnology and healthcare ecosystem together in Taip...
Menarini Asia-Pacific has announced an exclusive partnership with Pharmacosmos A/S to register, commercialise and distri...
Antibody-drug conjugates, GLP-1, dementia. Three Special Forums at BIO Asia-Taiwan 2026, three unrelated areas of medici...
On Wednesday the keynote argued that when AI compresses discovery, the constraint simply relocates: to manufacturing, ca...
Taiwan’s ambition to become one of Asia’s most consequential biotechnology hubs received a powerful ...
BIOSPECTRUM ASIA · DAY TWO ROUND-UP Day 1 belonged to the plenaries and the press. Day 2 was when ...
Cell therapy is approaching a defining transition: from highly specialised science to a reproducible, scalable pharmaceu...
The pharmaceutical industry’s innovation equation is changing. Developing an entirely new molecu...
The global CDMO market is moving beyond the era when manufacturing capacity alone defined competitive ...
As BioSpectrum Asia reports on the ground from BIO Asia–Taiwan 2026, being held from July 15–19 in T...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Longevity has never had a science problem so much as a business model problem. No regulator anywhere approves a drug for...
